Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NYSE:ABBV’

Smartest Countries in the World

Toronto-based Breton Hill Added These 5 Stocks to its Portfolio in Q1

Toronto-based Breton Hill Capital recently submitted its 13F filing with the SEC for the reporting period of March 31, revealing a U.S equity portfolio......(read more)
Wall Street Bull

Why Are Investors Excited About These 5 Stocks Today?

The markets are going nowhere today, after the IMF cut its global growth forecast for the fourth time over the past twelve months, due to China’......(read more)
background, modern, room,

Stocks Financial Advisors Are Interested In: Costco, Facebook & More

Last week was marked by the S&P 500 entering into its eighth year of bull run amid an increase in oil prices and hopes of more stimulus from central......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Do Hedge Funds Love AbbVie Inc (ABBV)?

After years of low interest rates, retail investors continue to starve for income while awaiting higher yields. The long-lasting low interest rate environment......(read more)
, group, growth, dream, dollar, earnings, photography, closeup, advertisement, heap, debt, nobody, rate, increment, income, yellow, stack, multiplication, finance

Five Dividend Aristocrats Hedge Funds Are Bullish On

Amid the latest market volatility, dividend investing is one of the safest bets on the equity markets. Large investors select dividend stocks not just......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

AbbVie Inc (ABBV): A Cheap Dividend Aristocrat Yielding Over 4%

AbbVie Inc (NYSE:ABBV) is one of the more controversial dividend aristocrats for several reasons. As a relatively new spin-off (2013), the company has......(read more)
Biotech Stocks 8

The Stock Picks of This Obscure Hedge Fund Returned 70.5% In 2015; See What It’s Betting On in 2016

Although Los Angeles-based, biotech-focused hedge fund DAFNA Capital Management has been in operation for the past 17 years, chances are that very few......(read more)
Felix Baker - Baker Bros.

Healthcare-focused Baker Bros. Advisors’ Top Picks: Incyte, Alexion, ACADIA & More

Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker. The firm focuses on life science and biotechnology companies......(read more)
GLENVIEW CAPITAL

Billionaire Larry Robbins’ Big Q4 Moves in Humana Inc. (HUM), CIGNA Corporation (CI) and Others

Billionaire Larry Robbins, the founder of Glenview Capital Management, has been among the most scrutinized and closely-watched hedge fund managers in......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Dividend Aristocrats Part 47: AbbVie Inc (ABBV)

AbbVie Inc (NYSE:ABBV) ranks very highly using The 8 Rules of Dividend Investing. The company’s stock has: – A 3.9% dividend yield – An......(read more)
Felix Baker - Baker Bros.

Top 5 Healthcare Bets of World-Class Baker Bros. Advisors

Baker Bros. Advisors is one of the most famous healthcare-focused equity hedge funds in the world today. It was founded in 2000 by brothers Julian Baker......(read more)
HIGHBRIDGE CAPITAL MANAGEMENT

Billionaire Glenn Russell Dubin’s 5 Best Stock Ideas for Q4

Highbridge Capital Management, led by Glenn Russell Dubin, recently filed its latest 13F with the U.S. Securities and Exchange Commission, revealing a......(read more)
GLENVIEW CAPITAL

Billionaire Larry Robbins Has Mixed Sentiment On His Top Picks For Q4

Glenview Capital, led by Larry Robbins, recently submitted its 13F with the Securities and Exchange Commission, disclosing the long positions held in......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

AbbVie Inc (ABBV): Are Hedge Funds Right About This Stock?

The equity market returns were very disappointing in the third quarter, “thanks” to the slowdown of China’s economy and the weaker-than-expected......(read more)
RENAISSANCE TECHNOLOGIES

Billionaire Jim Simons’ Top High-Dividend Stock Picks

Most individual investors invest in dividend-paying stocks to benefit from the steady streams of dividend checks, but can also take advantage of stock......(read more)
Mastercard Inc (NYSE:MA), cards, logo, sign, bank, credit, symbol, pay, finance, business

Here Are This Elite Fund’s Top Stock Picks

Christopher C. Grisanti‘s Grisanti Brown & Partners is a successful hedge fund with a focus on consumer and healthcare stocks. Mr. Grisanti......(read more)
Biotech Biochemical Stocks 3

Are Beech Hill Advisors’ Top Biotech Stock Picks Poised For A Big Q4?

Beech Hill Advisors is a New York-based registered investment advisor founded by Paul Cantor and Joseph Weiss in 1987. Mr. Cantor has been an investment......(read more)
Biotech Stocks 7

Woodford Investment Management Has A Lot Riding On These 5 Stocks

Woodford Investment Management recently filed its Form 13F with the U.S. Securities and Exchange Commission (SEC) for the reporting period of September......(read more)
GLENVIEW CAPITAL

A Look at Larry Robbins’ Take on the Pharma Industry and Four Picks He Is Bullish On

Larry Robbins of Glenview Capital is one of the most widely-watched investors on Wall Street. During the nine year period from 2001 until 2010, Glenview......(read more)
Wall Street Stocks Market Insider Trading

Why Are These Four Stocks on the Move on Friday?

With the stock market ending the week on a positive note, boosted by strong earnings reported by tech giants, a number of stocks are trending amid large......(read more)
17 Most Drug Addicted Countries in the World in 2017

AbbVie, Biogen, Gilead: Smart Money Got Burned Betting on Biotech in Q3

When it rains, it pours, and for big pharma, it certainly poured in the third quarter. With the third quarter over, let’s take a closer look at ......(read more)
Citigroup Inc (NYSE:C), Citi, Sign, building, Logo, Symbol

These Stocks Were Upgraded This Morning And Hedge Funds Couldn’t Agree More

Analysts have been busy over the weekend, as a slew of stocks have received upgrades this morning, including one company which was on the receiving end......(read more)
GLENVIEW CAPITAL

Here’s What Excited Hedge Funds Have To Say About AbbVie Inc (ABBV)

The $98.24 billion biopharmaceutical company AbbVie Inc (NYSE:ABBV) has sparked the attention of quite a few hedge funds according to the data we compiled......(read more)
pharmaceuticals-385950_1280

Billionaire Larry Robbins Has Healthy Stakes In Health Stocks

Glenview Capital, led by Larry Robbins, has recently published its 13F filing with the SEC, disclosing an equity portfolio worth $25.25 billion. The......(read more)
Facebook Inc (NASDAQ:FB), LIKE logo, sign, share, comment, logo, thumb, yes

Hedge Funds Are Pouring Money Into These Stocks

With the data from the latest round of 13F filings now gathered and processed, we’ve identified five stocks that received a large influx of cash in......(read more)
pharma 3

Synageva Biopharma Corp (GEVA) Acquisition Helps Baker Bros. Advisors Top All Others In Q2 Returns

With the rapid pace of M&A happening in the biotechnology sector, Julian Baker and Felix Baker‘s Baker Bros. Advisors is making a habit of hitting......(read more)
Sergey Nivens/shutterstock.com

Deerfield Management Bets Big On Company It Polished Ahead Of IPO, Nivalis Therapeutics Inc (NVLS)

Following the initial public offering of Nivalis Therapeutics Inc (NASDAQ:NVLS) today, James E. Flynn‘s Deerfield Management, which was a stakeholder......(read more)
hxdbzxy/shutterstock.com

Deerfield Management’s Top Health Stocks ~ Auspex Pharmaceuticals Inc (ASPX), Horizon Pharma PLC (HZNP), AbbVie Inc (ABBV)

James Flynn‘s Deerfield Management has filed its 13F with the SEC for the reporting period of March 31, with the investment manager disclosing ......(read more)
GLENVIEW CAPITAL

AbbVie Is Buying Back $5 Billion in Stock. Hurray?

Who likes AbbVie (NYSE:ABBV) stock? AbbVie does! In fact, this pharmaceutical industry big-cap likes itself so much, it’s planning to buy back $......(read more)
AbbVie Inc (NYSE:ABBV)

AbbVie Inc (ABBV), Verizon Communications Inc. (VZ): Grisanti Brown & Partners’ Latest 13F Shows Focus on Consumer & Healthcare Stocks

Grisanti Brown & Partners is a multi-billion hedge fund, which focuses on Consumer and Healthcare stocks, managed by Christopher C. Grisanti. It......(read more)
Kris Jenner - Rock Springs Capital

Kris Jenner’s Rock Springs Capital Rides Healthcare Stocks to Big Q1 Gains

Rock Springs Capital Management, managed by Kris Jenner, Gordon Bussard, and Graham McPhail, a healthcare-focused fund based in Baltimore, Maryland rode......(read more)
PAULSON & CO

John Paulson Big Bet On Whiting Petroleum Corp (WLL) Goes Sour With 64% Decline

Paulson & Co’s John Paulson is one billionaire who would love to forget the past two years, which have turned out to be his worst as wrong energy......(read more)
Gilead Sciences, Inc. (NASDAQ:GILD)

Express Scripts Holding Company (ESRX) Shuts Out Gilead Sciences Inc. (GILD) On A Cheaper Hepatitis C Treatment

Express Scripts Holding Company (NASDAQ:ESRX) desire to accord Hepatitis C patients with  what it believes to be the best of care has seen it ink a discounted......(read more)
best gold ETF

Hedge Fund News: John Paulson, Steven Cohen & Sandell Asset Management

Paulson Tripled Shire Stake Before Deal Fell Apart (Finalternatives) John Paulson clearly did not see the collapse of pharmaceutical giant AbbVie Inc (......(read more)
Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences Inc (GILD) And Merck & Co Inc (MRK) Fighting For 3 Billion-Per-Quarter Profits

Gilead Sciences, Inc. (NASDAQ:GILD), AbbVie Inc (NYSE:ABBV) and Merck & Co., Inc. (NYSE:MRK) have participated at the liver meeting in Boston, Massachusetts......(read more)
Steve Cohen SAC CAPITAL ADVISORS

Hedge Fund News: Steven Cohen, Carl Icahn & Lansdowne Partners

New Name, New Office, Similar Performance for Steven Cohen (NYTimes) The best thing federal prosecutors might have done for Steven A. Cohen, the billionaire......(read more)
Bruce Kovner, Caxton Associates LP

Hedge Fund News: Bruce Kovner, Seth Klarman & Brevan Howard

Caxton Hedge Fund Hires Former BNP Paribas Trader Fourcade (BusinessWeek) Caxton Associates LP, the hedge fund firm co-founded by billionaire Bruce Kovner......(read more)
Infinity Pharmaceuticals Inc. (NASDAQ:INFI)

Infinity Pharmaceuticals Inc. (INFI) and AbbVie Inc (ABBV) Stand Together Against Cancer

AbbVie Inc (NYSE:ABBV) will provide Infinity Pharmaceuticals Inc. (NASDAQ:INFI) with $275 million to fortify a new venture to develop new treatments......(read more)
best gold ETF

Shire PLC (ADR) (SHPG), Time Warner Cable (TWC): How John Paulson Got His Mojo Back

John Paulson’s funds posted strong returns in June, especially on the back of merger arbitrage plays, an activity in which Paulson has been involved......(read more)
AbbVie Inc (NYSE:ABBV)

AbbVie Inc (ABBV) Seals Deal With Shire (SHPG), What Next?

AbbVie Inc (NYSE:ABBV) finally bought Dublin-based Shire PLC (ADR) (NASDAQ:SHPG) for 32 billion pounds or $54.7 billion after several unsuccessful bids......(read more)
Shire PLC (ADR)

AbbVie Inc. (ABBV) Closing on a $53 Billion Takeover of Shire PLC (ADR) (SHPG)

Questions are being asked as to whether Shire PLC (ADR) (NASDAQ:SHPG) shareholders will finally agree to the latest offer of £53.20 by AbbVie Inc. (NYSE......(read more)
AbbVie Inc (NYSE:ABBV)

Dividend Announcements Today: AbbVie, Cantel Medical and More

In a spate of dividend declarations today on June 19, 2014, AbbVie Inc. (NYSE:ABBV), IBERIABANK Corp (NASDAQ:IBKC), Cantel Medical Corp. (NYSE:CMN) and......(read more)
AbbVie Inc (NYSE:ABBV)

Highline Capital Management Bets on Healthcare, Basic Materials & Services Stocks

Highline Capital Management is a fund led by Jacob Doft. Founded in 1995, Highline is a long/short equity hedge fund which has an equity portfolio worth......(read more)
Gilead Sciences, Inc. (NASDAQ:GILD)

Rock Springs Capital Management’s Top 5 Largest Stock Picks

Rock Springs Capital Management is a Baltimore-based hedge fund founded in February 2013 by Kris Jenner. Prior to that, Jenner had spent  14 years working......(read more)
Ken Fisher FISHER ASSET MANAGEMENT

Ken Fisher’s Stock Picks In The Dividend Space

Ken Fisher stocks:  Ken Fisher’s stock purchases and his portfolio overview originally published at long-term-investments.blogspot.com. I often look......(read more)
ChemoCentryx Inc (NASDAQ:CCXI)

AbbVie Inc (ABBV), GlaxoSmithKline plc (ADR) (GSK): Does ChemoCentryx Inc (CCXI) Have a Platform Problem?

It hasn’t been a fun month to be an investor in clinical-stage biotech ChemoCentryx Inc (NASDAQ:CCXI). After announcing at the end of August that......(read more)
AstraZeneca plc (ADR) (NYSE:AZN)

Do Hedge Funds and Insiders Love AstraZeneca plc (ADR) (AZN)?

What’s a smart AstraZeneca plc (ADR) (NYSE:AZN) investor to do? At the moment, there are dozens of gauges investors can use to track Mr. Market......(read more)
Celgene Corporation (NASDAQ:CELG)

Celgene Corporation (CELG), Onyx Pharmaceuticals, Inc. (ONXX), Johnson & Johnson (JNJ): When Will the Good News End for This Biotech?

They say that bad news comes in threes. I’m not sure if there’s a similar saying for good news, but for Celgene Corporation (NASDAQ:CELG)......(read more)
GlaxoSmithKline plc (ADR) (NYSE:GSK)

This Metric Says You Are Smart to Buy GlaxoSmithKline plc (ADR) (GSK)

What’s a smart GlaxoSmithKline plc (ADR) (NYSE:GSK) investor to do? In the financial world, there are many methods market participants can use......(read more)
AbbVie Inc (NYSE:ABBV)

AbbVie Inc (ABBV): Are Hedge Funds Right About This Stock?

Is it smart to be bullish on AbbVie Inc (NYSE:ABBV)? Now, according to many investors, hedge funds are seen as overrated, outdated investment tools of......(read more)